Decision making for promising quinoline-based anticancer agents through combined methodology
Yükleniyor...
Tarih
2020
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
WILEY
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
During the development of effective drugs for the treatment of cancer, one of the most important tasks is to identify effective drug candidates having maximum antiproliferation and minimum side effects. This paper considers the problem of selecting the most promising anticancer agents, showing inhibition at low IC50 concentration and low releasing lactate dehydrogenase percentage (cytotoxicity). Recently, we prepared quinoline analogs bearing different functional groups and determined their anticancer potential against the HeLa, C6, and HT29 cancer cell lines using different anticancer assays. Experimentally, seven quinoline derivatives consisting of different substituents were determined as promising anticancer agents. We propose a multicriteria recommendation method to identify the most promising anticancer agents against all tested cell lines with an accurate prediction algorithm according to the available input data. A multicriteria decision-making methodology (MCDM) was used for the solution of the relevant problem in this study. Both the experimental results and MCDM method indicated that 5,7-dibromo-8-hydroxyquinoline (2) and 6,8-dibromo-1,2,3,4-tetrahydroquinoline (6) are the most promising anticancer agents against the HeLa, HT29, and C6 cell lines.
Açıklama
Okten, Salih/0000-0001-9656-1803; OZCAN, Evrencan/0000-0002-3662-6190
Anahtar Kelimeler
anticancer effect, IC50, LDH, multicriteria decision making, quinoline
Kaynak
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
WoS Q Değeri
Q2
Scopus Q Değeri
Q2
Cilt
34
Sayı
9
Künye
Bu makale açık erişimli değildir.
